Skip to content
Home/Companies/Pharma/LEO Pharma

LEO Pharma

Pharma·Denmark·Active·5yr hold
Entry
2021
Hold
5yr
Status
Active

Who owns LEO Pharma?

LEO Pharma is currently owned by Nordic Capital through Nordic Capital Fund X (2020 vintage), since 2021.

Hand-verified · updated 2026-08-18

Nordic Capital
Investor
Nordic Capital
Nordic Capital Fund X · 2020 · Buyout

Key facts

HQDenmark
SectorPharma
StatusActive

More from Nordic Capital Fund X

Other portfolio companies in the same fund.

Ascot Lloyd
Active
FinancialsUK· 2022
Bilthouse
Active
FintechGermany· 2022
Care Fertility
Care Fertility
Active
HealthcareUK· 2022
Equashield
Active
MedTechUS· 2022
One Inc
One Inc
Active
InsurTechUS· 2022
Siteimprove
Siteimprove
Active
SaaSDenmark· 2022

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track LEO Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy LEO Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on LEO Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue